ACM Research (ACMR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
21 Aug, 2026Business overview and product portfolio
Supplies semiconductor equipment globally, serving leading manufacturers with differentiated technology that enhances yields and reduces chemical use.
Holds over 594 patents across the U.S., China, Japan, Singapore, South Korea, and Taiwan as of 12/31/25.
Operates advanced production facilities in Shanghai and Korea, with an Oregon demo lab and production center under construction.
Product lines include cleaning, ECP, furnace, PECVD, track, advanced packaging, and related services.
Integrated circuit wet cleaning equipment covers over 90% of cleaning process steps.
Financial performance and targets
Achieved a 42% revenue CAGR over the past five years, with FY25 revenue reaching $901M.
Q2 2026 revenue was $292.9M, up 36% year-over-year, with a GAAP gross margin of 46%.
Q2 2026 GAAP operating income was $49.7M (17% of revenue), and diluted GAAP EPS was $1.23.
Long-term internal target set for $4B+ in annual revenue, based on expanding product portfolio and market share.
Balance sheet shows $1,133M in cash and equivalents at Q2 2026 end.
Market and customer base
Estimated 2025 serviceable available market (SAM) of $22B, with cleaning, PECVD, track, furnace, plating, and advanced packaging as key segments.
Revenue mix in 2025: 52.2% from top four customers, with significant exposure to memory, foundry/logic, and packaging sectors.
Global footprint includes headquarters in Fremont, CA, and major R&D and manufacturing centers in China and Korea.
Latest events from ACM Research
- Q2 2026 revenue up 36% to $292.9M, with raised FY guidance and strong net income growth.ACMR
Q2 2026 - All director nominees and the independent auditor were approved by a strong shareholder quorum.ACMR
AGM 2026 - Q1 2026 revenue up 34%, driven by innovation, global expansion, and new product launches.ACMR
Investor presentation - Q1 2026 revenue rose 34.2% to $231.3M, with strong ECP growth and $110M raised from share sale.ACMR
Q1 2026 - Shareholders will vote virtually on director elections, auditor ratification, and strong governance practices.ACMR
Proxy filing - 2025 revenue rose 15.2% to $901.3M, with expanding global reach and product innovation.ACMR
Investor presentation - 2025 revenue hit $901.3M, with 2026 guidance for 21–30% growth despite margin pressure.ACMR
Q4 2025 - Q2 revenue up 40% to $202.5M, margins strong, 2024 guidance raised, new products launched.ACMR
Q2 2024 - Q3 revenue up 21% to $204M, net income up 20%, and 2024 guidance raised on strong global growth.ACMR
Q3 2024